Highlights and a hidden hazard - the FDA's new labeling regulations
Article Abstract:
The US Food and Drug Administration (FDA) is working to make the official descriptions of prescription drugs, known as package inserts or labeling, more helpful and user-friendly. However, along with these very modest alterations of drug labeling to be phased in over seven years beginning June 30, 2006, the changes include a provision that could severely limit the accountability of companies that fail to adequately evaluate or report the risks associated with their products.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Who should protect the public? The Supreme Court and medical device regulation
Article Abstract:
The Supreme Court's expected decision by June 2008, related to Charles Riegel versus Medtronic case is reviewed. The resolution could have great implication on government protection of consumers from the risks associated with medical devices and prescription drugs.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Immigrants are a positive part of the NHS. We should be open about resuscitation
- Abstracts: Clinical research and the NIH -- a report card. Public registration of clinical trials. Clinical research to clinical practice -- lost in translation?
- Abstracts: Giant-cell arteritis and polymyalgia rheumatica. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
- Abstracts: Healthier working lives across the UK. Putting on gloves. Gaining patient consent for blood tests following sharps injuries